Trademark: 90408328
Word
VYOQOV
Status
Pending
Status Code
733
Status Date
Tuesday, January 16, 2024
Serial Number
90408328
Mark Type
4000
Filing Date
Wednesday, December 23, 2020
Published for Opposition
Tuesday, November 23, 2021

Trademark Owner History
Inovio Pharmaceuticals, Inc. - Owner At Publication

Classifications
5 Pharmaceuticals for the prevention and treatment of diseases caused by coronaviruses; preparations, namely, pharmaceutical preparations for the prevention and treatment of diseases caused by coronavirus and vaccine preparations
42 Research and development in the field of pharmaceuticals and pharmaceutical preparations

Trademark Events
Jan 18, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 16, 2024
Sou Extension 4 Granted
Jan 16, 2024
Sou Extension 4 Filed
Jan 16, 2024
Sou Teas Extension Received
Jul 18, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 14, 2023
Sou Extension 3 Granted
Jul 14, 2023
Sou Extension 3 Filed
Jul 14, 2023
Sou Teas Extension Received
Jan 7, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 5, 2023
Sou Extension 2 Granted
Jan 5, 2023
Sou Extension 2 Filed
Jan 5, 2023
Sou Teas Extension Received
Jun 14, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 10, 2022
Sou Extension 1 Granted
Jun 10, 2022
Sou Extension 1 Filed
Jun 10, 2022
Sou Teas Extension Received
Jan 18, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 23, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 23, 2021
Published For Opposition
Nov 3, 2021
Notification Of Notice Of Publication E-Mailed
Oct 18, 2021
Approved For Pub - Principal Register
Oct 12, 2021
Teas/Email Correspondence Entered
Oct 12, 2021
Correspondence Received In Law Office
Oct 12, 2021
Teas Response To Office Action Received
Apr 16, 2021
Notification Of Non-Final Action E-Mailed
Apr 16, 2021
Non-Final Action E-Mailed
Apr 16, 2021
Non-Final Action Written
Apr 15, 2021
Assigned To Examiner
Mar 11, 2021
New Application Office Supplied Data Entered
Dec 26, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24